Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
vaccin recombinant contre le virus de l'hépatite B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
10 µg/0,5 ml du vaccin contre l'hépatite B recombinant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hepatitis b virus vaccine re 10mcg/0.5 mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hepatitis b virus vaccine re 10mcg/.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
seringue préremplie de 0,5 mL avec 20 microgrammes/mL du vaccin injectable contre l'hépatite B (ADNr) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hib-HB Haemophilus influenzae de type B + hépatite B pédiatrique non spécifié |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
seringue préremplie de 0,5 mL avec une suspension injectable d'antigène de surface du virus de l'hépatite B recombinant 10 microgrammes, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, vaccin acellulaire contre la coqueluche 25 microgrames |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
vaccin contre la diphtérie, le tétanos, la coqueluche et l'hépatite B recombinant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite et de l'hépatite B recombinant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite, l'hépatite B (recombinant) et Haemophilus influenzae de type B (recombinant) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
6 |
seringue préremplie de 0,5 mL avec une suspension injectable d'antigène de surface du virus de l'hépatite B recombinant 10 microgrammes, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, vaccin acellulaire contre la coqueluche 25 microgrames |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin recombinant contre le virus de l'hépatite B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |